Clinical Trial Update: Intraoperative Hyaluronic Acid Gel Injection for Improvement of Scar Quality Following Reduction Mammaplasty [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intraoperative hyaluronic acid gel injection to improve scar quality after reduction mammaplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cicatrix

Drugs mentioned

• Hyaluronic acid gel (hyaluronic acid gel)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Cicatrix | Phase 3 | Status: WITHDRAWN